<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01529177</url>
  </required_header>
  <id_info>
    <org_study_id>metformin for spermatogenesis</org_study_id>
    <nct_id>NCT01529177</nct_id>
  </id_info>
  <brief_title>Metformin for the Treatment of Unexplained Oligozspermia</brief_title>
  <official_title>Metformin for the Treatment of Unexplained Oligozspermia and Azoospermia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The Egyptian IVF-ET Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The Egyptian IVF-ET Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Insulin resistance (IR) in men may be the underlying pathogenesis for metabolic abnormalities
      and chronic hypospermatogenesis similar to women with polycystic ovarian disease (PCOD).
      Infertile men with unexplained infertility and IR may benefit from treatment with metformin.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Recently insulin resistance (IR) has been recognized as the underlying pathogenesis of
      chronic anovulation, hyperandrogenism, and metabolic abnormalities associated with PCOD in
      women. IR could be the underlying pathogenesis of chronic hypospermatogenesis leading to
      oligospermia and azoospermia associated with other metabolic abnormalities in men. Metformin
      has proven as an effective medication for not only IR but several other aspects of the PCOD
      including reproductive abnormalities. Therefore, insulin sensitizers, particularly metformin
      can be introduced as a pharmaceutical option for unexplained oligozoospermia and azoospermia
      associated with insulin resistance.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>February 2012</start_date>
  <completion_date type="Anticipated">February 2017</completion_date>
  <primary_completion_date type="Anticipated">September 2016</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>sperm count</measure>
    <time_frame>6 months</time_frame>
    <description>semen analysis before the start of metformin and then every month for 6 months</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>abnormal forms of spermatozoa</measure>
    <time_frame>6 months</time_frame>
    <description>semen analysis before the start of metformin and then every month for 6 months</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">600</enrollment>
  <condition>Infertility</condition>
  <arm_group>
    <arm_group_label>Metformin / clomid / hCG</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Metformin 1000 mg orally to be given daily for one week then twice daily for 2 weeks then 3 times daily for 6 months.
After 3 months from starting metformin the participant will receive 2 more medications in addition to metformin:
Clomid 50 mg orally per day and 5000 IU human chorionic gonadotrophin (hCG ) IM once per week for three months.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Clomid / hCG</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Clomid 50 mg per day will be administered orally and human chorionic gonadotrophin ( choriomon ) 5000 IU will be administered IM once per week. Both medications will be given for 6 month.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Metformin / clomid / hCG</intervention_name>
    <description>Metformin 1000 mg daily for a week then twice daily for 2 weeks then 3 tomes daily for 6 months.</description>
    <arm_group_label>Metformin / clomid / hCG</arm_group_label>
    <other_name>Glucophage / clomiphene citrate / choriomon</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Clomiphene citrate / hCG</intervention_name>
    <description>Clomiphene citrate 50 mg daily for one month, then twice daily for 2 months then 3 times per day for 3 months.</description>
    <arm_group_label>Clomid / hCG</arm_group_label>
    <other_name>Clomid / choriomon</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  oligospermia ( &lt; 10 million per mil-litter )

          -  normal FSH

          -  high insulin

        Exclusion Criteria:

          -  abnormal karyotype

          -  obstructive azoospermia
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ragaa mansour, MD,PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Egyptian IVF-ET Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>The Egyptian IVF-ET center</name>
      <address>
        <city>Cairo</city>
        <zip>11431</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ragaa mansour</last_name>
      <phone>20225254955</phone>
      <email>ragaa.mansour@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Ragaa mansour, MD,PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>August 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 4, 2012</study_first_submitted>
  <study_first_submitted_qc>February 7, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 8, 2012</study_first_posted>
  <last_update_submitted>August 5, 2015</last_update_submitted>
  <last_update_submitted_qc>August 5, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 7, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>The Egyptian IVF-ET Center</investigator_affiliation>
    <investigator_full_name>Ragaa Mansour</investigator_full_name>
    <investigator_title>Director</investigator_title>
  </responsible_party>
  <keyword>Metformin</keyword>
  <keyword>Insulin resistance</keyword>
  <keyword>male infertility</keyword>
  <keyword>unexplained Oligozspermia</keyword>
  <keyword>Clomiphene citrate</keyword>
  <keyword>Unexplained azoospermia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infertility</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Metformin</mesh_term>
    <mesh_term>Citric Acid</mesh_term>
    <mesh_term>Clomiphene</mesh_term>
    <mesh_term>Enclomiphene</mesh_term>
    <mesh_term>Zuclomiphene</mesh_term>
    <mesh_term>Chorionic Gonadotropin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

